Local neurochemicals and site-specific immune regulation in the CNS

Journal of Neuropathology and Experimental Neurology

Volumn 59, Issue 3, 2000, Pages 177-187

  Mccluskey, Lynnette Phillips ^a,b   Lampson, Lois A ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

Brainstem; Glutamate; Hippocampus; Major histocompatibility complex (MHC); NMDA receptors; Substance P; T cells

Indexed keywords

CYTOKINE; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN; NEUROTRANSMITTER;

ANIMAL CELL; ANTIGEN EXPRESSION; BRAIN; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM; DISEASE EXACERBATION; IMMUNITY; IMMUNOREGULATION; NERVOUS SYSTEM INJURY; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; T LYMPHOCYTE;

EID: 0034097279     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/59.3.177     Document Type: Review

References (68)

1. Meeson AP, Piddlesden S, Morgan BP, Reynolds R. The distribution of inflammatory demyelinated lesions in the central nervous system of rats with antibody-augmented demyelinating EAE. Exp Neurol 1994;129:299-310
2. Ericsson A, Liu C, Hart RD, Sawchenko PE. Type I interleukin-1 receptor in the rat brain: Distribution, regulation, and relationship to sites of IL-1 induced cellular activation. J Comp Neurol 1995;311:681-98
3. Berger T, Weerth S, Kojima K, Linington C, Wekerle H, Lassman H. EAE: The antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system. Lab Invest 1997;76:355-64
4. Peng Z-C, Kristensson K, Bentivoglio M. Distribution and temporal regulation of the immune response in the rat brain to intracerebro-ventricular injection of interferon-γ. Exp Neurol 1998;154:403-17
5. Phillips LM, Simon PJ, Lampson LA. Site-specific immune regulation in the brain: Differential modulation of major histocompatibility complex (MHC) proteins in brainstem vs hippocampus. J Comp Neurol 1999;405:322-33
6. Phillips LM, Lampson LA. Site-specific control of T cell traffic in the brain: T cell entry to brainstem vs hippocampus after local injection of IFN-γ. J Neuroimmunol 1999;96:218-27
7. Barker CF, Billingham RE. Immunologically privileged sites. Adv Immunol 1977;25:1-54
8. Streilein JW. Immune privilege as the result of local tissue barriers and immunosuppressive microenvironments. Curr Opinion Immunol 1993;5:428-32
9. Ferguson TA, Griffith TS. A vision of cell death: Insights into immune privilege. Immunol Rev 1997;156:167-84
10. Lampson LA, Kushner PD, Sobel RA. Major histocompatibility antigen expression in the affected tissues in amyotrophic lateral sclerosis. Ann Neurol 1990;28:365-72
11. Lampson LA. Basic principles of CNS immunology. In: Winn HR, ed. Youman's neurological surgery, 5th ed., WB Saunders, in press.
12. Tyor WR, Glass JD, Griffin JW et al. Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol 1992;31:349-60
13. Huynh H, Dorovini-Zis, K. Effects of interferon-gamma on primary cultures of human brain microvessel endothelial cells. Am J Pathol 1993;142:1265-78
14. Hauzenberger D, Klominek J, Bergstrom S-E, Sundqvist K-G. T lymphocyte migration: The influence of interactions via adhesion molecules, the T cell receptor and cytokines. Crit Rev Immunol 1995;15:285-316
15. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. Induction by IL-1 and IFN-γ: Tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 1986;137:245-54
16. Male D, Pryce G. Synergy between interferons and monokines in MHC induction on brain endothelium. Immunol Letters 1988;17: 267-71
17. Fabry Z, Waldschmidt MM, Hendrickson D, et al. Adhesion molecules on murine brain microvascular endothelial cells: Expression and regulation of ICAM-1 and Lgp 55. J Neuroimmunol 1992;36:1-11
18. McCarron RM, Wang L, Racke MK, McFarlin DE, Spatz M. Cytokine-regulated adhesion between encephalitogenic T lymphocytes and cerebrovascular endothelial cells. J Neuroimmunol 1993;43:23-30
19. Lampson LA, Chen A, Vortmeyer AO, Sloan AE, Ghogawala Z, Kim L. Enhanced T cell migration to sites of microscopic CNS disease: Complementary treatments evaluated by 2-and 3-D image analysis. Brain Pathol 1994;4:125-34
20. McGeer PL, Kawamata T, Walker DG, Akiyama H, Tooyama I, McGeer EG. Microglia in degenerative neurological disease. Glia 1993;7:84-92
21. Lampson LA. Interpreting MHC class I expression and class I/II reciprocity in the CNS: Reconciling divergent findings. Micros Res Tech 1995;32:267-85
22. Vass K, Lassmann H. Intrathecal application of interferon gamma: Progressive appearance of MHC antigens within the rat nervous system. Am J Pathol 1990;137:789-800
23. Sethna MP, Lampson LA. Immune modulation within the brain: Recruitment of inflammatory cells and increased major histocompatibility antigen expression following intracerebral infection of interferon-γ. J Neuroimmunol 1991;34:121-32
24. Weigent DA, Blalock JE. Production of peptide hormones and neurotransmitters by the immune system. Neuroimmunoendocrinol 1997;69:1-30
25. de Waal RM. The anti-inflammatory activity of glucocorticoids. Mol Biol Reports 1994;19:81-88
26. Payan DG, Goetzl EJ. Modulation of lymphocyte function by sensory neuropeptides. J Immunol 1985;135:783s-786s
27. Tang SC, Braunsteiner H, Wiedermann CJ. Regulation of human T lymphoblast growth by sensory neuropeptides: Augmentation of CCK-induced inhibition of Molt-4 proliferation by somatostatin and VIP in vitro. Immunol Lett 1992;34:237-42
28. Nio DA, Moylan RN, Roche JK. Modulation of T lymphocyte function by neuropeptides. J Immunol 1993;150:5281-88
29. Levite M. Neuropeptides, by direct interaction with T cells, induce cytokine secretion and break the commitment to a distinct T helper phenotype. Proc Natl Acad Sci. USA 1998;95:12544-49
30. Zimmerman BJ, Anderson DC, Granger DN. Neuropeptides promote neutrophil adherence to endothelial cell monolayers. Am J Physiol 1992;263:G678-82
31. Vishwanath R, Mukherjee R. Substance P promotes lymphocyte-endothelial cell adhesion preferentially via LFA-1/ICAM-1 interactions. J Neuroimmunol 1996;71:163-71
32. Goebeler M, Henseleit U, Roth J, Sorg C. Substance P and calcitonin gene-related peptide modulate leukocyte infiltration to mouse skin during allergic contact dermatitis. Arch Dermatol Res 1994;286:341-46
33. Kähler CM, Kaufmann G, Hogue-Angeletti R et al. A soluble gradient of the neuropeptide secretoneurin promotes the transendothelial migration of monocytes in vitro. Eur J Pharmacol 1999;365:65-75
34. Horwitz MS, Evans CF, Klier FG, Oldstone MBA. Detailed in vivo analysis of interferon-γ induced major histocompatibility complex expression in the central nervous system: Astrocytes fail to express MHC class I and II molecules. Lab Invest 1999;79:235-42
35. Cannella B, Aquino DA, Raine CS. MHC II expression in the CNS after long-term demyelination. J Neuropathol Exp Neurol 1995;54: 521-30
36. Fontana A, Fierz W, Wekerle H. Astrocytes present myelin basic protein to encephalitogenic T cell lines. Nature 307;273-76
37. Wen P, Lampson MA, and Lampson LA. Effects of gamma interferon on major histocompatibility complex antigen expression and lymphocytic infiltration in the 9L gliosarcoma brain tumor model: Implications for strategies of immunotherapy. J Neuroimmunol 1992;36:57-68
38. Tontsch U., Rott O. Cortical neurons selectively inhibit MHC class II induction in astrocytes but not in microgliat cells. Int Immunol 1993;5:249-54
39. Lee N, Collins M, Vanguri P, Shin ML. Glutamate differentially inhibits the expression of class II MHC antigens on astrocytes and microglia. J Immunol 1992;148:3391-97
40. Neumann H, Schmidt, Cavalie A, Jenne D, Wekerle H. Major histocompatibility complex (MHC) class I gene expression in single neurons of the central nervous system: Differential regulation by interferon (IFN)-γ and tumor necrosis factor (TNF)-α. J Exp Med 1997;185:305-16
41. Frohman EM, Vayuvegula B, van den Noort S, Gupta S. Norepinephrine inhibits gamma-interferon-induced MHC class II (Ia) antigen expression on cultured brain astrocytes. J Neuroimmunol 1988;17:89-101
42. Phillips LM, Lampson LA. Immunomodulation in the CNS by classical neuromolecules. Soc for Neurosci Abstracts 1999;477.17
43. 1differentially regulates proliferation and MHC class-II antigen expression in forebrain and brainstem astrocyte primary cultures. Brain Res 1992;585:229-36
44. Shinoda, H, Marini AM, Cosi C, Schwartz JP. Brain region and gene specificity of neuropeptide gene expression in cultured astrocytes. Science 1989;245:415-17
45. Hopkins SJ, Rothwell NJ. Cytokines and the nervous system I. Expression and recognition. Trends Neurosci 1995;18:83-88
46. Rothwell NJ, Hopkins SJ. Cytokines and the nervous system II. Actions and mechanisms of action. Trends Neurosci 1995;18:130-36
47. Breder CD, Hazuka C, Ghayur T et al. Regional induction of tumor necrosis factor-_ expression in the mouse brain after systemic lipopolysaccharide expression. Proc Natl Acad Sci 1994;91:11393-97
48. Andersson P-B, Perry VH, Gordon S. Intracerebral injection of proinflammatory cytokines or leukocyte chemotaxins induces minimal myelomonocytic cell recruitment to the parenchyma of the central nervous system. J Exp Med 1992;176:255-59
49. Craigie EH. On the relative vasculanty of various parts of the central nervous system of the albino rat. J Comp Neurol 1920;31:429-64
50. Weiss HR, Buchweitz E, Murtha TJ, Auletta M. Quantitative regional determination of morphometric indices of the total and perfused capillary network in the rat brain. Circ Res 1982;51:494-503
51. Lightman SL, Caspi RR, Nussenblatt RB, Palastine AG. Antigen-directed retention of an autoimmune T-cell line. Cell Immunol 1987;110:28-34
52. Hickey WF, Hsu BL, Kimura H. T-lymphocyte entry into the central nervous system. J Neurosci Res 1991;28:254-60
53. Ludowyk PA, Willenborg DO, Parish CR. Selective localisation of neuro-specific T lymphocytes in the central nervous system. J Neuroimmunol 1992;37:237-50
54. Lampson LA. Beyond inflammation: Site-directed immunotherapy. Immunol Today 1998;19:17-22
55. Lawson LJ, Perry VH, Dri P, Gordon S. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neurosci 1990;39:151-70
56. Cras P, Kawai M, Siedlak S et al. Neuronal and microglial involvement in β-amyloid protein deposition in Alzheimer's disease. Am J Pathol 1990;137:241-46
57. Kato H, Kogure K, Araki T, Itoyama Y. Graded expression of immunomolecules on activated microglia in the hippocampus following ischemia in a rat model of ischemic tolerance. Brain Res 1995;694:85-93
58. Pedersen EB, McNulty JA, Castro AJ, Fox LM, Zimmer J, Finsen B. Enriched immune-environment of blood-barrier deficient areas of normal adult rats. J Neuroimmunol 1997;76:117-31
59. Moore TC. Modification of lymphocyte traffic by vasoactive neurotransmitter substances. Immunol 1984;52:511-18
60. Bozic CR, Lu B, Hopken UE, Gerard C, Gerard NP. Neurogenic amplification of immune complex inflammation. Science 1996;273: 1722-25
61. Cuello AC, Kanazawa I. The distribution of substance P immunoreactive fibers in the rat central nervous system. J Comp Neurol 1978;178:129-56
62. 9]SP binding sites in the guinea pig and rat brain. Brain Res 1994;633:317-25
63. Schenk D, Barbour R, Dunn W et al. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 1999;400:173-77
64. Spencer DC, Price RW. Human immunodeficiency virus and the central nervous system. Ann Rev Microbiol 1992;46:655-93
65. Stoll G, Sebastian J, Schroeter M. Inflammation and glial responses in ischemic brain lesions. Prog Neurobiol 1998;56:149-71
66. Brownell B, Hughes JT. The distribution of plaques in the cerebrum in multiple sclerosis. J Neurol Neurosurg Psychiatr 1962;25:315-20
67. Adams CWM. Color atlas of multiple sclerosis and other myelin disorders. Dobbs Ferry, NY: Sheridan Medical Books, 1989.
68. Lampson LA. Molecular bases of neuronal individuality: Lessons from anatomical and biochemical studies with monoclonal antibodies. In Kennett RH et al. eds. Monoclonal antibodies and functional cell lines: Progress and applications. Plenum Press, 1984:153-89